FDA Drug recall D-1032-2020
Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901
- FDA Drug
- Class II
- terminated
- Published 2020-03-25
On 2020-03-25 the FDA classified a Class II recall of Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901 by Sun Pharmaceutical Industries, citing CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1032-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-03-13 |
| Published | 2020-03-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sun Pharmaceutical Industries |
| Distribution | US |
Product
Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.
Reason
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Identifiers
| ndc | 63304-614-20 |
|---|---|
| ndc | 63304-614-05 |
| ndc | 63304-614-01 |
| ndc | 63304-614-13 |
| ndc | 63304-615-05 |
| ndc | 63304-615-11 |
| ndc | 63304-615-01 |
| ndc | 63304-616-20 |
| ndc | 63304-616-05 |
| ndc | 63304-616-01 |
| ndc | 63304-616-13 |
| ndc | 63304-616-50 |
| code_info | Lot #: AA39490, Exp 03/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1032-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.